195 related articles for article (PubMed ID: 30365936)
21. Tumor-suppressive microRNA-143/145 cluster targets hexokinase-2 in renal cell carcinoma.
Yoshino H; Enokida H; Itesako T; Kojima S; Kinoshita T; Tatarano S; Chiyomaru T; Nakagawa M; Seki N
Cancer Sci; 2013 Dec; 104(12):1567-74. PubMed ID: 24033605
[TBL] [Abstract][Full Text] [Related]
22. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
23. MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2.
Hui L; Zhang J; Guo X
Biomed Pharmacother; 2018 Jul; 103():1194-1201. PubMed ID: 29864898
[TBL] [Abstract][Full Text] [Related]
24. The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma.
Jin F; Wang Y; Zhu Y; Li S; Liu Y; Chen C; Wang X; Zen K; Li L
Sci Rep; 2017 Jun; 7(1):3089. PubMed ID: 28596599
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA PVT1 promotes glycolysis and tumor progression by regulating miR-497/HK2 axis in osteosarcoma.
Song J; Wu X; Liu F; Li M; Sun Y; Wang Y; Wang C; Zhu K; Jia X; Wang B; Ma X
Biochem Biophys Res Commun; 2017 Aug; 490(2):217-224. PubMed ID: 28602700
[TBL] [Abstract][Full Text] [Related]
26. [miR-125b suppresses the aerobic glycolysis of osteosarcoma HOS cells by downregulating the expression of hexokinase-2].
Wu Y; He H; Wu B; Wen J; Guo Z; Luo Y; Cao G
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Oct; 33(10):1365-1370. PubMed ID: 29169422
[TBL] [Abstract][Full Text] [Related]
27. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression.
Deng Y; Zhao F; Hui L; Li X; Zhang D; Lin W; Chen Z; Ning Y
J Ovarian Res; 2017 Jul; 10(1):50. PubMed ID: 28743276
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-181b inhibits glycolysis in gastric cancer cells via targeting hexokinase 2 gene.
Li LQ; Yang Y; Chen H; Zhang L; Pan D; Xie WJ
Cancer Biomark; 2016 Jun; 17(1):75-81. PubMed ID: 27314295
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2.
Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C
Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893
[TBL] [Abstract][Full Text] [Related]
31. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy.
Zhang XY; Zhang M; Cong Q; Zhang MX; Zhang MY; Lu YY; Xu CJ
Int J Biochem Cell Biol; 2018 Feb; 95():9-16. PubMed ID: 29247711
[TBL] [Abstract][Full Text] [Related]
32. miR-206 regulates non-small-cell lung cancer cell aerobic glycolysis by targeting hexokinase 2.
Jia KG; Feng G; Tong YS; Tao GZ; Xu L
J Biochem; 2020 Apr; 167(4):365-370. PubMed ID: 31742336
[TBL] [Abstract][Full Text] [Related]
33. MiR-199a-5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer.
Guo W; Qiu Z; Wang Z; Wang Q; Tan N; Chen T; Chen Z; Huang S; Gu J; Li J; Yao M; Zhao Y; He X
Hepatology; 2015 Oct; 62(4):1132-44. PubMed ID: 26054020
[TBL] [Abstract][Full Text] [Related]
34. miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6.
Xia B; Yang S; Liu T; Lou G
Mol Cancer; 2015 Mar; 14():57. PubMed ID: 25889927
[TBL] [Abstract][Full Text] [Related]
35. The overexpression of hypomethylated miR-663 induces chemotherapy resistance in human breast cancer cells by targeting heparin sulfate proteoglycan 2 (HSPG2).
Hu H; Li S; Cui X; Lv X; Jiao Y; Yu F; Yao H; Song E; Chen Y; Wang M; Lin L
J Biol Chem; 2013 Apr; 288(16):10973-85. PubMed ID: 23436656
[TBL] [Abstract][Full Text] [Related]
36. MiR-199a targeting ROCK1 to affect kidney cell proliferation, invasion and apoptosis.
Qin Z; Wei X; Jin N; Wang Y; Zhao R; Hu Y; Yan W; Li J; Zhou Q
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):1920-1925. PubMed ID: 29130345
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-107 induces cell cycle arrests by directly targeting cyclin E1 in ovarian cancer.
Tang Z; Fang Y; Du R
Biochem Biophys Res Commun; 2019 Apr; 512(2):331-337. PubMed ID: 30885433
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.
Chen X; Dong C; Law PT; Chan MT; Su Z; Wang S; Wu WK; Xu H
Gynecol Oncol; 2015 Dec; 139(3):513-9. PubMed ID: 26472353
[TBL] [Abstract][Full Text] [Related]
39. The prognostic effect of PTEN expression status in colorectal cancer development and evaluation of factors affecting it: miR-21 and promoter methylation.
Yazdani Y; Farazmandfar T; Azadeh H; Zekavatian Z
J Biomed Sci; 2016 Jan; 23():9. PubMed ID: 26787105
[TBL] [Abstract][Full Text] [Related]
40. miR-145 promotes miR-133b expression through c-myc and DNMT3A-mediated methylation in ovarian cancer cells.
Li J; Zhang S; Zou Y; Wu L; Pei M; Jiang Y
J Cell Physiol; 2020 May; 235(5):4291-4301. PubMed ID: 31612498
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]